Contineum Therapeutics . Class A Common Stock Stock Forecast

Sell candidate since Jun 22, 2026

The Contineum Therapeutics, Inc. Class A stock price fell by -2.68% on the last day (Monday, 22nd Jun 2026) from $11.94 to $11.62. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 8.11% from a day low at $11.47 to a day high of $12.40. The price has fallen in 6 of the last 10 days but is still up by 1.13% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -129 thousand shares and in total, 185 thousand shares were bought and sold for approximately $2.14 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $11.21 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.36% during the next 3 months and, with a 90% probability hold a price between $10.61 and $13.75 at the end of this 3-month period.

CTNM Signals & Forecast

There are mixed signals in the stock today. The Contineum Therapeutics, Inc. Class A stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.08 and $13.06. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 2.83%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Contineum Therapeutics, Inc. Class A stock

Contineum Therapeutics, Inc. Class A finds support from accumulated volume at $11.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.93 between high and low, or 8.11%. For the last week, the stock has had daily average volatility of 9.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTNM) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Contineum Therapeutics, Inc. Class A Common Stock to open at $11.83, and during the day (based on 14 day Average True Range), to move between $11.17 and $12.07, which gives a possible trading interval of +/-$0.90 (+/-8.04%) up or down from last closing price. If Contineum Therapeutics, Inc. Class A Common Stock takes out the full calculated possible swing range there will be an estimated 8.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.49 (1.12%) than the resistance at $12.33 (6.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Contineum Therapeutics, Inc. Class A Common Stock stock A Buy?

Contineum Therapeutics, Inc. Class A holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.688 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $11.83 ( 1.81%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk